David T Rubin

99PUBLICATIONS
223CO-AUTHORS
Health counsellingMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (99)

|Jul 10, 2026
Healthcare professionals' knowledge, attitudes, and practice with addressing sexual health among people living with inflammatory bowel disease: A UK cross-sectional survey.

|Jun 26, 2026
Combined bowel urgency, clinical outcomes, and quality of life improvement in mirikizumab-treated ulcerative colitis: a step toward comprehensive disease management.

|Jun 22, 2026
Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn's disease.

|Jun 09, 2026
Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients with Baseline Cardiovascular Risk.

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|May 14, 2026
Evaluation of a pharmacist directed treat to target approach in patients with inflammatory bowel disease receiving upadacitinib or risankizumab.

Pageof 17

Frequent Collaborators

8 joint publications

Silvio Danese

6 joint publications

Siew C Ng

5 joint publications

David K Choi

5 joint publications

Amelia Kellar